Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
MicroRNA 518a-2 (MIR518A2) is a short, non-coding RNA molecule, classified as a microRNA, involved in the post-transcriptional regulation of gene expression in multicellular organisms[1][4]. MicroRNAs are transcribed as primary transcripts and sequentially processed by Drosha and Dicer RNases to produce a mature miRNA, which then becomes part of the RNA-induced silencing complex (RISC) and regulates target mRNAs through translational inhibition or mRNA degradation[1][3][4]. While broad classes of microRNAs are known to play essential regulatory roles in cancer and other diseases, there is currently no evidence that MIR518A2 itself functions as a direct therapeutic target or has clinically validated drug interactions[1][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on MicroRNA 518a-2 (MIR518A2).